Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Screener
News
About

AXGN - Axogen, Inc. Latest News | Finranks

Home

/

AXGN

A

Axogen, Inc. (AXGN)

NCM – Real Time Price. Currency in USD

40.93

+0.14 (0.34%)

At close: May 12, 2026, 4:00 PM EDT

40.97

+0.04 (0.10%)

After-hours: May 12, 2026, 7:50 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

ALACHUA, Fla. and TAMPA, Fla.

Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript

Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript

Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript

AxoGen (AXGN) Q1 Earnings Lag Estimates

AxoGen (AXGN) Q1 Earnings Lag Estimates

AxoGen (AXGN) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.12 per share. This compares to a loss of $0.02 per share a year ago.

Axogen, Inc. Reports First Quarter 2026 Financial Results

Axogen, Inc. Reports First Quarter 2026 Financial Results

ALACHUA, Fla. and TAMPA, Fla.

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth

AxoGen (AXGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?

AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?

AxoGen (AXGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026

Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026

ALACHUA, Fla. and TAMPA, Fla.

Videos

No Data

There is no data to display

Press releases

Axogen, Inc. Reports First Quarter 2026 Financial Results

Axogen, Inc. Reports First Quarter 2026 Financial Results

ALACHUA, Fla. and TAMPA, Fla.

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

22.01.2026

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

ALACHUA, Fla. and TAMPA, Fla.

Axogen Announces Proposed Public Offering of Common Stock

Axogen Announces Proposed Public Offering of Common Stock

ALACHUA, Fla. and TAMPA, Fla.

Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025

Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025

ALACHUA, Fla. and TAMPA, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced preliminary unaudited fourth quarter and full-year 2025 key financials.